NCT00277264 - Spiriva® Assessment of FEV1 (SAFE) | Biotech Hunter

Enrollment

914

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium (Spiriva®)

Trial Locations (96)

T1Y 6J4

Respiratory Research, Room 1742, Calgary

T2N 4N1

Boehringer Ingelheim Investigational Site, Calgary

T2V 1P9

4A-185, 7007-14 Street SW, Calgary

T5G 3G6

Boehringer Ingelheim Investigational Site, Edmonton

T1J 0Z2

Boehringer Ingelheim Investigational Site, Lethbridge

T1A 4E4

Boehringer Ingelheim Investigational Site, Medicine Hat

T7X 2Z8

301-131 First Ave., Spruce Grove

T9A 3N3

Boehringer Ingelheim Investigational Site, Wetaskiwin

V2S 6R6

Boehringer Ingelheim Investigational Site, Abbotsford

V2P 4M9

Boehringer Ingelheim Investigational Site, Chilliwack

V1W 3T1

Boehringer Ingelheim Investigational Site, Kelowna

V2X 2L5

Boehringer Ingelheim Investigational Site, Maple Ridge

V3L 1H6

220 Royal Avenue, New Westminster

V2A 3G6

Penticton Regional Hospital, Penticton

V3V 1N1

Boehringer Ingelheim Investigational Site, Surrey

V5Z 3J5

Boehringer Ingelheim Investigational Site, Vancouver

V5Z 4E1

Boehringer Ingelheim Investigational Site, Vancouver

V6Z !Y6

Boehringer Ingelheim Investigational Site, Vancouver

V8R 6V4

Boehringer Ingelheim Investigational Site, Victoria

R0A 2T3

Boehringer Ingelheim Investigational Site, Steinbach

R2K 3S8

1095 Concordia Avenue, Winnipeg

E2M 3W5

Boehringer Ingelheim Investigational Site, Saint John

A1N 2C3

Boehringer Ingelheim Investigational Site, Mount Pearl

A1A 3R5

262 Newfoundland Drive, St. John's

A1B 3V6

300 Prince Philip Drive, St. John's

B2H 1K1

Boehringer Ingelheim Investigational Site, New Glasgow

B1P 1P3

Boehringer Ingelheim Investigational Site, Sydney

L1S 2J5

Boehringer Ingelheim Investigational Site, Ajax

N0N 1G0

Boehringer Ingelheim Investigational Site, Corunna

L1E 3C3

Boehringer Ingelheim Investigational Site, Courtice

L3M 1P3

169 Main Street East, Grimsby

L8L 2X2

237 Barton Street East, Hamilton

HGH McMaster Clinic, Hamilton

L8M 1K7

Boehringer Ingelheim Investigational Site, Hamilton

L8N 4A6

50 Charlton Avenue East, Hamilton

L8V 1C1

Boehringer Ingelheim Investigational Site, Hamilton

K7L 5E4

Boehringer Ingelheim Investigational Site, Kingston

N2C 2N9

Boehringer Ingelheim Investigational Site, Kitchener

N5W 6A2

Boehringer Ingelheim Investigational Site, London

N6A 4G5

Boehringer Ingelheim Investigational Site, London

Haemolology Division, London

N6A 4V2

St Joseph's Healthcare, London

N6A 5R9

Boehringer Ingelheim Investigational Site, London

L6B 1A1

Boehringer Ingelheim Investigational Site, Markham

L4W 1N2

Boehringer Ingelheim Investigational Site, Mississauga

L5B 1N1

300-2338 Hurontario Street, Mississauga

L5M 2V8

Boehringer Ingelheim Investigational Site, Mississauga

L2G 1J4

Boehringer Ingelheim Investigational Site, Niagara Falls

M2K 2W2

Boehringer Ingelheim Investigational Site, North York

M2K 2Z3

Boehringer Ingelheim Investigational Site, North York

K1H 8L6

Ottawa Hospital - General Campus, Ottawa

K1Y 4E9

1053 Carling Avenue, Ottawa

K1Y 4G2

Boehringer Ingelheim Investigational Site, Ottawa

K1Y 4P6

Boehringer Ingelheim Investigational Site, Ottawa

K9J 7H8

Boehringer Ingelheim Investigational Site, Peterborough

L4C 2N9

Boehringer Ingelheim Investigational Site, Richmond Hill

N7T 4X3

Boehringer Ingelheim Investigational Site, Sarnia

M1B 4Z8

Boehringer Ingelheim Investigational Site, Scarborough Village